A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and Pleasure
Condition: Depressive Disorder, Major · Anhedonia · Sponsor: Janssen Research & Development, LLC
About this study
The purpose of this study is to assess how well aticaprant works compared to placebo when given in addition to antidepressant therapy (selective serotonin reuptake inhibitor \[SSRI\] or serotonin-norepinephrine reuptake inhibitor \[SNRI\]) in preventing return of depression symptoms in participants with major depressive disorder who experience a loss of interest and pleasure and who achieve a stable response after treatment with adjunctive aticaprant.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (95)
| Preferred Research Partners | Little Rock, Arkansas, United States | — |
| Wake Research PRI Encino | Encino, California, United States | — |
| Wr Pri Llc | Newport Beach, California, United States | — |
| ATP Clinical Research | Orange, California, United States | — |
| Myndful Research | Redlands, California, United States | — |
| Artemis Institute for Clinical Research | San Diego, California, United States | — |
| UHC Research | Doral, Florida, United States | — |
| Pharmax Research Clinic Inc | Miami, Florida, United States | — |
| GTL Medical and Research Group | Miami, Florida, United States | — |
| International Research Associates, LLC | Miami, Florida, United States | — |
| Harmony Clinical Research Inc | North Miami Beach, Florida, United States | — |
| APG Research LLC | Orlando, Florida, United States | — |
+ 83 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06635135